Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial
Summary
Background An increased rate of brain atrophy is often observed in older subjects, in particular those who suffer from cognitive decline. Homocysteine is a risk factor for brain atrophy, cognitive impairment and dementia. Plasma concentrations of homocysteine can be lowered by dietary administration of B vitamins. Objective To determine whether supplementation with B vitamins that lower levels of plasma total homocysteine can slow the rate of brain atrophy in subjects with mild cognitive impairment in a randomised controlled trial (VITACOG, ISRCTN 94410159). Methods and Findings Single-center, randomized, double-blind controlled trial of high-dose folic acid, vitamins B6 and B12 in 271 individuals (of 646 screened) over 70 y old with mild cognitive impairment. A subset (187) volunteered to have cranial MRI scans at the start and finish of the study. Participants were randomly assigned to two groups of equal size, one treated with folic acid (0.8 mg/d), vitamin B12 (0.5 mg/d) and vitamin B6 (20 mg/d), the other with placebo; treatment was for 24 months. The main outcome measure was the change in the rate of atrophy of the whole brain assessed by serial volumetric MRI scans. Results A total of 168 participants (85 in active treatment group; 83 receiving placebo) completed the MRI section of the trial. The mean rate of brain atrophy per year was 0.76% [95% CI, 0.63–0.90] in the active treatment group and 1.08% [0.94–1.22] in the placebo group (P = 0.001). The treatment response was related to baseline homocysteine levels: the rate of atrophy in participants with homocysteine >13 µmol/L was 53% lower in the active treatment group (P = 0.001). A greater rate of atrophy was associated with a lower final cognitive test scores. There was no difference in serious adverse events according to treatment category. Conclusions and Significance The accelerated rate of brain atrophy in elderly with mild cognitive impairment can be slowed by treatment with homocysteine-lowering B vitamins. Sixteen percent of those over 70 y old have mild cognitive impairment and half of these develop Alzheimer's disease. Since accelerated brain atrophy is a characteristic of subjects with mild cognitive impairment who convert to Alzheimer's disease, trials are needed to see if the same treatment will delay the development of Alzheimer's disease. Trial Registration Controlled-Trials.com http://www.controlled-trials.com/ISRCTN94410159/94410159
Related articles
Overview of Radiographic Imaging Techniques
This document presents personal notes detailing the principles and techniques of radiographic imaging, including the operation of X-ray equipment, technical competencies of radiographers, and the anatomy of the X-ray tube. It aims to provide a comprehensive understanding of radiography as both an art and science.
IMAGE PRODUCTION & FILM PROCESSING
This document provides comprehensive guidelines for the dark room processes involved in radiography, including the environmental controls, required equipment, and procedures for efficient film processing.
Nutrition and Laboratory Preparation: A Comprehensive Guide
This document outlines fundamental concepts of laboratory preparation, nutrition assessment, diagnosis, intervention, and meal planning, emphasizing the importance of accurate measurements and procedures in both food preparation and nutrition care.
Emergency and Disaster Nursing Care of Clients in Acute Biologic Crisis
This document provides a comprehensive overview of emergency nursing care practices, focusing on the triage process and management of clients in acute biologic crises. It details the principles of emergency care, the roles of nursing in emergency situations, and the importance of proper documentation and consent.
Filtration in an X-ray Tube (Detailed Notes)
This document provides detailed notes on the process of filtration in X-ray tubes, explaining how it removes low-energy X-rays to enhance image quality and reduce patient radiation dose. It covers types of filtration, including inherent and added filtration, and their significance in radiology.